Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone MetastasesAndrew L. Himelstein, Charles L. Shapiro, Douglas Weckstein et al.|JAMA|2017Cited by 357